Citalytics was founded by two Life Sciences veterans that each bring nearly 20 years of industry-specific knowledge to our clients. Together, they lead the bulk of consulting, data acquisition, and analysis for Citalytics’ clients.
Co-Founder, Director of Technology and Algorithm Development
Brad loves toying with unstructured data and experimenting with the latest text mining methods which is why he handles our algorithm development and deployment. He brings a strong background in statistics with nearly 15 years of life sciences industry experience to our client projects.
Brad did his PhD work in Statistics with an emphasis in nonparametric statistics from UC Davis and a did post-doc in Statistics at the Max Plank Institute for Demography in Rostock, Germany. After that he worked in applied statistical roles with microarrays, image analysis, pathway analysis, sequence analysis, variant detection, as well as classical survival analysis, design of experiment at Molecular Dynamics (bought by Amersham), InforMax (bought by Invitrogen then became Life Technologies) and BioReliance (bought by Sigma-Aldrich).
Brad has always enjoyed chatting with co-workers and collaborating to solve interesting problems. The data acquisition algorithms we use at Citalytics are an output of some of those projects.
Co-Founder, Director of Marketing & Business Development
Pete’s past roles and experience working for companies large and small fuel his passion for helping our clients with their data and analysis projects. He knows what it’s like to have to manage and grow product lines with lackluster data, which is why he jumps at any opportunity to help our clients address their data woes.
Pete started his career in Operations working in the diagnostics industry for Abbott Laboratories and Gen-Probe before transitioning into leadership roles in marketing and product development for life science technology firms. While working at Genset Oligos, Pete managed the US marketing tactics for new oligo applications in qPCR and gene silencing (siRNA) in the earliest days.
During his busy tenor at Invitrogen, Pete managed product development and successful launch campaigns for 10 product lines supporting miRNA analysis, array-CGH, serial analysis of gene expression (SAGE), and array-based gene expression profiling. In 2007, Pete launched EpiGenie, a news site covering the rapidly evolving field of epigenetics, stem cells, and synthetic biology which still operates today.
Pete brings his 16 years of product development, management, and digital marketing experience into every Citalytics project, providing our clients with valuable direction.